{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:52Z","timestamp":1791259672367,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.bcmd.2004.08.013","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T15:29:25Z","timestamp":1096385365000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation"],"prefix":"10.1016","volume":"33","author":[{"given":"Ulrike","family":"Koehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Gr\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2004.08.013_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0268-960X(03)00063-8","article-title":"Haploidentical transplantation for acute lymphoblastic leukemia in childhood","volume":"18","author":"Klingebiel","year":"2004","journal-title":"Blood Reviews"},{"key":"10.1016\/j.bcmd.2004.08.013_bib2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T cell depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2004.08.013_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2004.08.013_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor lymphocyte infusion in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2004.08.013_bib5","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor killer cell alloreactivity in mismatched hematopoietic transplants","volume":"100","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2004.08.013_bib6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2004.08.013_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2141.1997.d01-2101.x","article-title":"Allogeneic MHC mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukemia effect","volume":"96","author":"Zeiss","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2004.08.013_bib8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and clinical relevance of human natural killer cells","volume":"76","author":"Robertson","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2004.08.013_bib9","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2004.08.013_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.175.3.779","article-title":"Response of human killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF","volume":"175","author":"Robertson","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2004.08.013_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2004.08.013_bib12","first-page":"159","article-title":"Positive selection of hematopoietic progenitor cells for autologous and allogeneic transplantation in pediatric patients with solid tumors and leukemia","volume":"vol. 1","author":"Koehl","year":"1999"},{"key":"10.1016\/j.bcmd.2004.08.013_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bmt.1703558","article-title":"Autologous transplantation of CD133 selected haematopoietic progenitor cells in a paediatric patient with relapsed leukemia","volume":"29","author":"Koehl","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2004.08.013_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.bmt.1703406","article-title":"Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children","volume":"29","author":"Lang","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2004.08.013_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.gt.3301977","article-title":"Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes","volume":"10","author":"Junker","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcmd.2004.08.013_bib16","first-page":"652","article-title":"Characterization of a human cell line NK-92 with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2004.08.013_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.leu.2402760","article-title":"Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience","volume":"1","author":"Koehl","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2004.08.013_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2141.2001.02906.x","article-title":"Non MHC-restricted cytotoxic cells: their roles in the control and treatment of leukemias","volume":"114","author":"Lowdell","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2004.08.013_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/meth.1996.0044","article-title":"Antitumor functions of natural killer cells and control of metastases","volume":"9","author":"Vujanovic","year":"1996","journal-title":"Methods"},{"key":"10.1016\/j.bcmd.2004.08.013_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2003-12-4438","article-title":"Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells","volume":"104","author":"Igarashi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2004.08.013_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1702669","article-title":"Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantation","volume":"26","author":"Passweg","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2004.08.013_bib22","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1038\/sj.leu.2403083","article-title":"Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukaemia (B-CLL): a potential source for cellular immunotherapy","volume":"17","author":"Guven","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2004.08.013_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00262-002-0298-y","article-title":"Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-enriched supernatant","volume":"51","author":"Grityppis","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcmd.2004.08.013_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14653240310004548","article-title":"Ex vivo expansion of natural killer cells for clinical applications","volume":"6","author":"Klingemann","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bcmd.2004.08.013_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determination of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J. Immunol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979604001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979604001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:21:38Z","timestamp":1761049298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979604001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1079979604001718"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2004.08.013","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2004.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}